SARASOTA, Fla., June 15, 2004 (PRIMEZONE) -- The following is an investment opinion issued by eLocity Inc.:
GLOBAL TRIAD, INC. (Pink Sheets:GTRD), Atrix Laboratories Inc. (Nasdaq:ATRX) and Evolving Systems, Inc. (Nasdaq:EVOL).
Investors may want to swing over and check out a little known company called GLOBAL TRIAD, INC. (Pink Sheets:GTRD). GLOBAL announced on Monday after the closing bell, the signing of a Letter of Intent with AMPLIDYNE INC., a recognized leader in the design and manufacture of wireless networking products, whereby Amplidyne will supply GLOBAL TV, INC., a wholly owned subsidiary of Global Triad, with the technology and products required for GTRD to continue realizing its vision of becoming a major player in the wireless networking community. Amplidyne, Inc. designs, manufactures and sells ultra linear single and multi-channel power amplifiers and broadband high-speed wireless products to the worldwide wireless, local loop and satellite uplink telecommunications market. Global Triad Incorporated (GTI) is a holding company with headquarters in Sarasota, Florida. It is the Company's intent to become a leading force in the digital communications sector through a combination of organic growth and mergers or acquisitions of complimentary businesses. GTRD is currently trading between .75 -- 1.00 a share.
On the Nasdaq making a move was Evolving Systems, Inc. (Nasdaq:EVOL). Evolving Systems announced on Monday that a major U.S. telecommunications carrier has selected the Company's NumeriTrack(tm) solution as the number inventory platform for its voice over Internet protocol (VoIP) initiative. NumeriTrack is a highly efficient, cost-effective inventory solution for carriers who must comply with the FCC mandate for a comprehensive number conservation policy. The solution will be used to handle all VoIP phone number management in and out of region for the carrier's VoIP offering. EVOL traded 8,661,244 shares Monday to end at $5.75, up $1.20 (26.37%).
In other news, QLT Inc., a specialty pharmaceutical company, said Monday it agreed to buy Atrix Laboratories Inc. (Nasdaq:ATRX) or about $855 million in cash and stock in a move to diversify its revenue base and drug portfolio. Under the agreement, expected to close sometime this year, Atrix shareholders will receive one common share of QLT plus $14.61 in cash for each Atrix share held. ATRX traded 13,399,844 shares Monday to end at $31.39, up $3.37 (12.03%).
About eLocity Inc: eLocity owns and operates three financial websites for investors.
-Bell2Bell.com, http://www.bell2bell.com/. Bell2Bell features news stories, rumors, the InvestBoard and more.
-PennyPicks.com, http://www.pennypicks.com/. Featuring active message boards for the penny stock trader, rumors and more.
-StockGrid.com, http://www.stockgrid.com/. Visit this site for our daily top stock "GRID Makers". We rank stocks on volume, message board activity, sentiment and trend forecast.
Sign up for FREE at any of the sites above.
The newsletter is provided by eLocity Inc., an electronic broadcaster and publisher of this newsletter, here after referred to as "the company". The company is to receive compensation for this newsletter service for GLOBAL TRIAD, INC. only. The compensation is one thousand dollars from a non-affiliated third party, Audra Inc. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.
The company reserves the right to trade in securities mentioned herein, and may make purchases or sales in such securities featured within our newsletter reports. The information contained in this publication is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented, nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. All statements of opinions, if any, (Our Summary) are those of the company.
The company relies exclusively on information gathered from the client, public filings on client, press releases and client's web site. Investors should use the information contained in this publication as a starting point for conducting additional research on the featured client in order to allow the investor to form his or her own opinion regarding the featured clients. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.
Investment in the clients reviewed is speculative and a high-risk and may result in the loss of some or all of any investment made in the client. This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended.
The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.